Literature DB >> 31106421

SP1-mediated overexpression of lncRNA LINC01234 as a ceRNA facilitates non-small-cell lung cancer progression via regulating OTUB1.

Jing-Jing Xie1, Qun-Yi Guo1, Jian-Ying Jin1, Dan Jin1.   

Abstract

Long noncoding RNAs (lncRNAs) have been confirmed to be strongly associated with the progression of various types of cancer. LncRNA LINC01234 (LINC01234) is a newly identified tumor-related lncRNA whose upregulation has been confirmed in some tumors. However, its potential expressions and possible functions in non-small-cell lung cancer (NSCLC) have not been explored. In this study, we first found that LINC01234 expressions were distinctly upregulated in both NSCLC samples and cell lines using RT-PCR. Our group also showed that LINC01234 upregulations were modulated by nuclear transcription factor SP1. The results form clinical investigations indicated that high LINC01234 expressions were associated with positively lymph node metastasis and advanced tumor-metastasis-node (TMN) stage. Kaplan-Meier assays indicated that patients with NSCLC having high LINC01234 expressions tend to have unfavorable clinical prognosis. Using multivariate assays, it was confirmed that LINC01234 was an independent prognostic factor for patients with NSCLC. In vitro assays showed that inhibition of LINC01234 suppressed NSCLC cell proliferation, cell colony formation and metastasis, and greatly promoted apoptosis. Mechanistic investigations revealed LINC01234 promotes the progression of NSCLC cells by the modulation of miR-140 to positively regulate OTUB1 expression. Taken together our findings, they provided an exhaustive assay of LINC01234 in NSCLC and imperative clues for insights into the potential effects of lncRNAs-miRNAs regulatory network in NSCLC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  OTUB1; lncRNA LINC01234; metastasis; miR-140; non-small-cell lung cancer; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31106421     DOI: 10.1002/jcp.28848

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.

Authors:  Muhua Chen; Chunfeng Zhang; Wei Liu; Xiaojuan Du; Xiaofeng Liu; Baocai Xing
Journal:  Mol Ther       Date:  2022-02-19       Impact factor: 12.910

2.  Long Non-Coding RNA LINC00491 Contributes to the Malignancy of Non-Small-Cell Lung Cancer via Competitively Binding to microRNA-324-5p and Thereby Increasing Specificity Protein 1 Expression.

Authors:  Xiaoning Zhang; Xia Zhao; Yanqing Wang; Liqun Xing
Journal:  Cancer Manag Res       Date:  2020-08-06       Impact factor: 3.989

3.  LINC01806 mediated by STAT1 promotes cell proliferation, migration, invasion, and stemness in non-small cell lung cancer through Notch signaling by miR-4428/NOTCH2 axis.

Authors:  Shangxiao Huang; Shixiong Liang; Jianfeng Huang; Penghui Luo; Dunchang Mo; Hanlei Wang
Journal:  Cancer Cell Int       Date:  2022-05-22       Impact factor: 6.429

4.  Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis.

Authors:  Jie Liang; Shujuan Zhang; Wei Wang; Yan Xu; Atikan Kawuli; Jiaqi Lu; Xuemei Xiu
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 5.  Competing endogenous RNAs in lung cancer.

Authors:  Meilian Zhao; Jianguo Feng; Liling Tang
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

6.  Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.

Authors:  Wei Zhang; Qian Zhang; Li Che; Zhefan Xie; Xingdong Cai; Ling Gong; Zhu Li; Daishun Liu; Shengming Liu
Journal:  BMC Cancer       Date:  2022-03-21       Impact factor: 4.430

7.  The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Juan Wang; Xu Han; Ye Yuan; Hao Gu; Xing Liao; Miao Jiang
Journal:  Front Genet       Date:  2022-04-05       Impact factor: 4.772

Review 8.  Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management.

Authors:  Yihao Liao; Diansheng Zhou; Pu Wang; Mengyue Yang; Ning Jiang
Journal:  Cell Death Discov       Date:  2022-06-17

9.  LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis.

Authors:  Jia Yu; Xinxin Zhang; Rongfang He; Xiaoyan Yang; Juan Hu; Fang Tan; Jinyu Yao; Xiaoyong Lei; Gebo Wen
Journal:  Dis Markers       Date:  2022-07-25       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.